gpc-addon apparatus (Agilent technologies)
Agilent technologies is a verified supplier 
Agilent technologies manufactures this product 
90
Structured Review
Agilent technologies
gpc-addon apparatus
Gpc Addon Apparatus, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gpc-addon+apparatus/pmc06487438-72-1-0
Average 90 stars, based on 1 article reviews
Gpc Addon Apparatus, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gpc-addon+apparatus/pmc06487438-72-1-0
Average 90 stars, based on 1 article reviews
gpc-addon apparatus - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Gel Permeation Chromatography:Article Title: PLA-PCL-PEG-PCL-PLA based micelles for improving the ocular permeability of dexamethasone: development, characterization, and in vitro evaluation. Article Snippet: The aim of the present research was to investigate the feasibility of developing polylactidepolycaprolactone-polyethylene glycolpolycaprolactone-polylactide (PLA-PCL-PEG-PCL-PLA) based micelles to improve ocular permeability of dexamethasone (DEX).. PLA-PCL-PEG-PCLPLA copolymers were synthesized by a ring-opening polymerization method.. DEX was loaded into the developed copolymers. Article Title: Docetaxel-Loaded Mixed Micelles and Polymersomes Composed of Poly (caprolactone)-Poly (ethylene glycol) (PEG-PCL) and Poly (lactic acid)-Poly (ethylene glycol) (PEG-PLA): Preparation and In-vitro Characterization Article Snippet: Article Title: Comparison of in-situ forming composite using PLGA-PEG-PLGA with in-situ forming implant using PLGA: In-vitro, ex-vivo, and in-vivo evaluation of naltrexone release Article Snippet: An in-situ forming composite (ISFC) of naltrexone (NTX) was prepared using PLGA-PEGPLGA (triblock) and N-methyl-2-pyrrolidone (NMP) for decreasing the initial burst release.. The supercritical CO2 method was used to achieve the ring-opening polymerization of the triblock.. The Box-Behnken design was used to achieve the minimal initial burst release of NTX in the invitro release medium. Article Title: An in-situ forming implant formulation of naltrexone with minimum initial burst release using mixture of PLGA copolymers and ethyl heptanoate as an additive: In-vitro, ex-vivo, and in-vivo release evaluation Article Snippet: An in-situ forming implant formulation of naltrexone (NTX) was achieved based on a minimum initial burst release of NTX in the in-vitro release medium using a Box-Behnken design.. Variables such as percent of copolymer by weight, copolymer composition (PLGA 756s: PLGA 504H), and percent ethyl heptanoate by weight as an additive in formulation were investigated.. The in-vitro, ex-vivo, and in-vivo release of the optimized formulation was investigated. Refractive Index:Article Title: PLA-PCL-PEG-PCL-PLA based micelles for improving the ocular permeability of dexamethasone: development, characterization, and in vitro evaluation. Article Snippet: The aim of the present research was to investigate the feasibility of developing polylactidepolycaprolactone-polyethylene glycolpolycaprolactone-polylactide (PLA-PCL-PEG-PCL-PLA) based micelles to improve ocular permeability of dexamethasone (DEX).. PLA-PCL-PEG-PCLPLA copolymers were synthesized by a ring-opening polymerization method.. DEX was loaded into the developed copolymers. Article Title: Docetaxel-Loaded Mixed Micelles and Polymersomes Composed of Poly (caprolactone)-Poly (ethylene glycol) (PEG-PCL) and Poly (lactic acid)-Poly (ethylene glycol) (PEG-PLA): Preparation and In-vitro Characterization Article Snippet: Article Title: Comparison of in-situ forming composite using PLGA-PEG-PLGA with in-situ forming implant using PLGA: In-vitro, ex-vivo, and in-vivo evaluation of naltrexone release Article Snippet: An in-situ forming composite (ISFC) of naltrexone (NTX) was prepared using PLGA-PEGPLGA (triblock) and N-methyl-2-pyrrolidone (NMP) for decreasing the initial burst release.. The supercritical CO2 method was used to achieve the ring-opening polymerization of the triblock.. The Box-Behnken design was used to achieve the minimal initial burst release of NTX in the invitro release medium. Article Title: An in-situ forming implant formulation of naltrexone with minimum initial burst release using mixture of PLGA copolymers and ethyl heptanoate as an additive: In-vitro, ex-vivo, and in-vivo release evaluation Article Snippet: An in-situ forming implant formulation of naltrexone (NTX) was achieved based on a minimum initial burst release of NTX in the in-vitro release medium using a Box-Behnken design.. Variables such as percent of copolymer by weight, copolymer composition (PLGA 756s: PLGA 504H), and percent ethyl heptanoate by weight as an additive in formulation were investigated.. The in-vitro, ex-vivo, and in-vivo release of the optimized formulation was investigated. Molecular Weight:Article Title: PLA-PCL-PEG-PCL-PLA based micelles for improving the ocular permeability of dexamethasone: development, characterization, and in vitro evaluation. Article Snippet: The aim of the present research was to investigate the feasibility of developing polylactidepolycaprolactone-polyethylene glycolpolycaprolactone-polylactide (PLA-PCL-PEG-PCL-PLA) based micelles to improve ocular permeability of dexamethasone (DEX).. PLA-PCL-PEG-PCLPLA copolymers were synthesized by a ring-opening polymerization method.. DEX was loaded into the developed copolymers. Article Title: Docetaxel-Loaded Mixed Micelles and Polymersomes Composed of Poly (caprolactone)-Poly (ethylene glycol) (PEG-PCL) and Poly (lactic acid)-Poly (ethylene glycol) (PEG-PLA): Preparation and In-vitro Characterization Article Snippet: Article Title: Comparison of in-situ forming composite using PLGA-PEG-PLGA with in-situ forming implant using PLGA: In-vitro, ex-vivo, and in-vivo evaluation of naltrexone release Article Snippet: An in-situ forming composite (ISFC) of naltrexone (NTX) was prepared using PLGA-PEGPLGA (triblock) and N-methyl-2-pyrrolidone (NMP) for decreasing the initial burst release.. The supercritical CO2 method was used to achieve the ring-opening polymerization of the triblock.. The Box-Behnken design was used to achieve the minimal initial burst release of NTX in the invitro release medium. Article Title: An in-situ forming implant formulation of naltrexone with minimum initial burst release using mixture of PLGA copolymers and ethyl heptanoate as an additive: In-vitro, ex-vivo, and in-vivo release evaluation Article Snippet: An in-situ forming implant formulation of naltrexone (NTX) was achieved based on a minimum initial burst release of NTX in the in-vitro release medium using a Box-Behnken design.. Variables such as percent of copolymer by weight, copolymer composition (PLGA 756s: PLGA 504H), and percent ethyl heptanoate by weight as an additive in formulation were investigated.. The in-vitro, ex-vivo, and in-vivo release of the optimized formulation was investigated. Synthesized:Article Title: PLA-PCL-PEG-PCL-PLA based micelles for improving the ocular permeability of dexamethasone: development, characterization, and in vitro evaluation. Article Snippet: The aim of the present research was to investigate the feasibility of developing polylactidepolycaprolactone-polyethylene glycolpolycaprolactone-polylactide (PLA-PCL-PEG-PCL-PLA) based micelles to improve ocular permeability of dexamethasone (DEX).. PLA-PCL-PEG-PCLPLA copolymers were synthesized by a ring-opening polymerization method.. DEX was loaded into the developed copolymers. Article Title: Docetaxel-Loaded Mixed Micelles and Polymersomes Composed of Poly (caprolactone)-Poly (ethylene glycol) (PEG-PCL) and Poly (lactic acid)-Poly (ethylene glycol) (PEG-PLA): Preparation and In-vitro Characterization Article Snippet: Article Title: Comparison of in-situ forming composite using PLGA-PEG-PLGA with in-situ forming implant using PLGA: In-vitro, ex-vivo, and in-vivo evaluation of naltrexone release Article Snippet: An in-situ forming composite (ISFC) of naltrexone (NTX) was prepared using PLGA-PEGPLGA (triblock) and N-methyl-2-pyrrolidone (NMP) for decreasing the initial burst release.. The supercritical CO2 method was used to achieve the ring-opening polymerization of the triblock.. The Box-Behnken design was used to achieve the minimal initial burst release of NTX in the invitro release medium. Article Title: An in-situ forming implant formulation of naltrexone with minimum initial burst release using mixture of PLGA copolymers and ethyl heptanoate as an additive: In-vitro, ex-vivo, and in-vivo release evaluation Article Snippet: An in-situ forming implant formulation of naltrexone (NTX) was achieved based on a minimum initial burst release of NTX in the in-vitro release medium using a Box-Behnken design.. Variables such as percent of copolymer by weight, copolymer composition (PLGA 756s: PLGA 504H), and percent ethyl heptanoate by weight as an additive in formulation were investigated.. The in-vitro, ex-vivo, and in-vivo release of the optimized formulation was investigated. |